Guest guest Posted November 3, 2011 Report Share Posted November 3, 2011 Latest info regarding APC-100, the Adamis Pharmaceutical Corporation anti-androgenic anti-inflammatory, signal transduction inhibitor drug demonstrated to have higher therapeutic activity than the current marketed Standard of Care anti-androgens. If they can keep getting necessary funding, we may be seeing this drug on the market in three or four more years. http://tinyurl.com/6xjfnma Wiech (I think that is his last name) provided a very good explanation of the difficulty that can accompany smaller research companies to get the funding necessary to move their product through the hurdles of trials and final approval for prescribing in his post two months ago. Chuck Always as close as the other end of your computer to help address any prostate cancer concerns. " What you leave behind is not what is engraved in stone monuments, but what is woven into the lives of others. " (Chuck) Maack - Prostate Cancer Advocate/Activist Email: maack1@... PCa Help: " Observations " http://www.theprostateadvocate.com Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.